Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

Item
http://www.wikidata.org/entity/Q34191006
Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect ProfileProbes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-olsIn vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor functionSynthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivityMost recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsDiscovery of novel triazole-based opioid receptor antagonists.μ Opioid receptor: novel antagonists and structural modeling.Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinonesMixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profileand Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
P2860

Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

Item
http://www.wikidata.org/entity/Q34191006
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Synthesis and biological evalu ...... ucture-activity relationships.
@ast
Synthesis and biological evalu ...... ucture-activity relationships.
@en
Synthesis and biological evalu ...... ucture-activity relationships.
@nl
type
label
Synthesis and biological evalu ...... ucture-activity relationships.
@ast
Synthesis and biological evalu ...... ucture-activity relationships.
@en
Synthesis and biological evalu ...... ucture-activity relationships.
@nl
prefLabel
Synthesis and biological evalu ...... ucture-activity relationships.
@ast
Synthesis and biological evalu ...... ucture-activity relationships.
@en
Synthesis and biological evalu ...... ucture-activity relationships.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Synthesis and biological evalu ...... ucture-activity relationships.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698